ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for pro Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
Merus NV

Merus NV (2GH)

42.00
0.80
(1.94%)
Closed January 05 3:00PM
Realtime Data

Empower your portfolio: Real-time discussions and actionable trading ideas.

Key stats and details

Current Price
42.00
Bid
41.40
Ask
42.40
Volume
160
41.60 Day's Range 42.00
25.20 52 Week Range 58.50
Previous Close
41.20
Open
41.60
Last Trade
10
@
41.6
Last Trade Time
Average Volume (3m)
189
Financial Volume
-
VWAP
-

2GH Latest News

Merus annonce le traitement du premier patient dans le cadre d’un essai de phase 2 portant sur le pétosemtamab dans le CCRm en 3e ligne et lignes ultérieures

Merus annonce le traitement du premier patient dans le cadre d’un essai de phase 2 portant sur le pétosemtamab dans le CCRm en 3e ligne et lignes ultérieures UTRECHT, Pays-Bas et CAMBRIDGE...

Merus gibt Verabreichung von petosemtamab an ersten Patienten in Phase-II-Studie bei 3L+ mCRC bekannt

Merus gibt Verabreichung von petosemtamab an ersten Patienten in Phase-II-Studie bei 3L+ mCRC bekannt UTRECHT, Niederlande und CAMBRIDGE, Massachusetts, Dec. 17, 2024 (GLOBE NEWSWIRE) -- Merus...

Merus announces First Patient Dosed in Phase 2 Trial of Petosemtamab in 3L+ mCRC

Merus announces First Patient Dosed in Phase 2 Trial of Petosemtamab in 3L+ mCRC UTRECHT, The Netherlands and CAMBRIDGE, Mass., Dec. 16, 2024 (GLOBE NEWSWIRE) -- Merus N.V. (Nasdaq: MRUS), a...

Les données intermédiaires de Merus portant sur le pétosemtamab continuent de démontrer une activité cliniquement significative dans le traitement de 2e ligne et lignes ultérieures du CETC r/m

Les données intermédiaires de Merus portant sur le pétosemtamab continuent de démontrer une activité cliniquement significative dans le traitement de 2e ligne et lignes ultérieures du CETC r/m...

Zwischenergebnisse der Monotherapie mit Petosemtamab von Merus zeigen weiterhin klinisch signifikante Aktivität bei 2L+ r/m HNSCC

Zwischenergebnisse der Monotherapie mit Petosemtamab von Merus zeigen weiterhin klinisch signifikante Aktivität bei 2L+ r/m HNSCC Studie mit Petosemtamab in Kombination mit Pembrolizumab bei 1L...

Merus’ Petosemtamab Monotherapy Interim Data Continues to Demonstrate Clinically Meaningful Activity in 2L+ r/m HNSCC

Merus’ Petosemtamab Monotherapy Interim Data Continues to Demonstrate Clinically Meaningful Activity in 2L+ r/m HNSCC Petosemtamab in combination with pembrolizumab in 1L r/m PD-L1 expressing...

Merus annonce l’autorisation par la FDA de BIZENGRI® (zénocutuzumab-zbco) dans le traitement de l’adénocarcinome pancréatique NRG1+ et du cancer du poumon non à petites cellules (CPNPC) NRG1+, en fonction des données de sécurité et d’efficaci

Merus annonce l’autorisation par la FDA de BIZENGRI® (zénocutuzumab-zbco) dans le traitement de l’adénocarcinome pancréatique NRG1+ et du cancer du poumon non à petites cellules (CPNPC) NRG1+, en...

Merus gibt FDA-Zulassung von BIZENGRI® (Zenocutuzumab-zbco) für NRG1+-Adenokarzinome der Bauchspeicheldrüse und NRG1+-nicht-kleinzelligen Lungenkrebs (NSCLC) auf der Grundlage von Sicherheits- und Wirksamkeitsdaten aus der eNRGy-Studie bekannt

Merus gibt FDA-Zulassung von BIZENGRI® (Zenocutuzumab-zbco) für NRG1+-Adenokarzinome der Bauchspeicheldrüse und NRG1+-nicht-kleinzelligen Lungenkrebs (NSCLC) auf der Grundlage von Sicherheits- und...

Merus Announces FDA Approval of BIZENGRI® (zenocutuzumab-zbco) for NRG1+ Pancreatic Adenocarcinoma and NRG1+ Non–Small Cell Lung Cancer (NSCLC) Based on Safety and Efficacy Data From the eNRGy Study

Merus Announces FDA Approval of BIZENGRI® (zenocutuzumab-zbco) for NRG1+ Pancreatic Adenocarcinoma and NRG1+ Non–Small Cell Lung Cancer (NSCLC) Based on Safety and Efficacy Data From the eNRGy...

Merus and Partner Therapeutics Announce License Agreement for the U.S. Commercialization of Zenocutuzumab in NRG1 Fusion-Positive Cancer

Merus and Partner Therapeutics Announce License Agreement for the U.S. Commercialization of Zenocutuzumab in NRG1 Fusion-Positive Cancer UTRECHT, The Netherlands and CAMBRIDGE, Mass., Dec. 02...

PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
10.2000010.47847130331341.7999994239.79999910540.92088525DE
4-0.799999-1.8691565857342.79999942.79999939.627940.99802788DE
12-6.6-13.580246913648.651.539.618944.53140804DE
26-8-16505439.617746.25299896DE
5215.659.090909090926.458.525.218344.878113DE
15618.276.470588235323.858.51917441.90952181DE
26018.276.470588235323.858.51917441.90952181DE

2GH - Frequently Asked Questions (FAQ)

What is the current Merus NV share price?
The current share price of Merus NV is 42.00 €
What is the 1 year trading range for Merus NV share price?
Merus NV has traded in the range of 25.20 € to 58.50 € during the past year

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
0S6Cerence Inc
18.972 €
(145.34%)
89.94k
CY9DMicrobot Medical Inc
2.11 €
(89.07%)
24.21k
RV0Torrent Gold Inc
0.138 €
(73.58%)
1.23k
7CCCheckCap Ltd
1.76 €
(55.75%)
6.55k
34Q0Quantum eMotion Inc
0.985 €
(53.91%)
1.62M
7DBDiamondback Energy Inc
9.7176 €
(-94.02%)
800
FASFastenal Co
9.7358 €
(-85.95%)
2.13k
1UR1Bee Vectoring Technologies International Inc
0.003 €
(-45.45%)
300.18k
B4T0CuFe Ltd
0.0045 €
(-25.00%)
1
H5EHelma Eigenheimbau Ag
0.0766 €
(-23.40%)
751
PF8European Lithium Limited
0.0264 €
(8.20%)
5.76M
3CPXiaomi Corporation
4.597 €
(7.34%)
3.95M
D7GNel ASA
0.247 €
(2.66%)
2.33M
J9AVERSES AI Inc
1.352 €
(0.00%)
1.67M
34Q0Quantum eMotion Inc
0.985 €
(53.91%)
1.62M

Discussion

View Full Feed
Spartanfan1 Spartanfan1 4 minutes ago
This should not be churning between .005-.01. Due for a run
ADIA
glenn1919 glenn1919 4 minutes ago
synx..................https://www.stockscores.com/charts/charts/?ticker=synx
flipper44 flipper44 5 minutes ago
No offense, but the shorts have succeeded in effecting battered long syndrome. SMH.
NWBO
OMOLIVES OMOLIVES 6 minutes ago
Maybe something to do with the sample size.
jour_trader jour_trader 7 minutes ago
All signs point to it, but don't think anyone is absolutely 100% certain. 
ELTP
gfp927z gfp927z 7 minutes ago
>>> VeriSign, Inc. (VRSN), together with its subsidiaries, provides domain name registry services and internet infrastructure that enables internet navigation for various recognized domain names worldwide. The company enables the security, stability, and resiliency of internet infrastructure and ser
VRSN
MartinLutherKing MartinLutherKing 8 minutes ago
Why doesn’t anyone in the scientific community believe in the nobel cancer clinical human micro rna TTX- Crispr trials with the fda

https://synapse.patsnap.com/blog/fda-approves-transcodes-phase-12-trial-of-ttx-mc138-for-advanced-solid-tumors
gfp927z gfp927z 10 minutes ago
>>> VeriSign, Inc. (VRSN), together with its subsidiaries, provides domain name registry services and internet infrastructure that enables internet navigation for various recognized domain names worldwide. The company enables the security, stability, and resiliency of internet infrastructure and ser
gp22 gp22 11 minutes ago
$SYNX: BIG week for $SYNX?
Exact copy & setup of Israel Military & USA Homeland Security 400% mover $SPCB...$SYNX volume was < 1M on Friday when it started to get found. Expect multi-30M share days next week like every other Israel Sector play that gets found.
Israel Sector just findi
SPCB SYNX
whitegold3 whitegold3 11 minutes ago
Good reply firebalka7, I'm still laughing at his ignorance
zab zab 11 minutes ago
President Biden sure goes America back after orange shittypants trump surrendered to Covid, but then you never really care about trump and the Republicans killing 1.3 million Americans when they controlled the American government.  Maybe trump will kill even more Americans in his second term. 
gp22 gp22 12 minutes ago
$SYNX: BIG week for $SYNX?
Exact copy & setup of Israel Military & USA Homeland Security 400% mover $SPCB...$SYNX volume was < 1M on Friday when it started to get found. Expect multi-30M share days next week like every other Israel Sector play that gets found.
Israel Sector just findi
SPCB SYNX
gfp927z gfp927z 12 minutes ago
>>> VeriSign, Inc. (VRSN), together with its subsidiaries, provides domain name registry services and internet infrastructure that enables internet navigation for various recognized domain names worldwide. The company enables the security, stability, and resiliency of internet infrastructure and ser
VRSN
real777mellon real777mellon 12 minutes ago
I literally just was wondering who would want to watch my X and share on a sophisticated email chain? Idk what you old guys call it. I was flattered. Relax with this all - you're hostility is forgetting you asked me who sued me and why I called Stankonia is bc the guy on X literally tried to sue.
LEHNQ
Rocky3 Rocky3 13 minutes ago
From (d) of https://app.quotemedia.com/data/downloadFiling?webmasterId=90423&ref=318820914&type=HTML&symbol=RVNC&cdn=9ee31753a5ab50dbf3b17b693fc78ca3&companyName=Revance+Therapeutics+Inc.&formType=SC+TO-T%2FA&formDescription=%5BAmend%5D+Tender+offer+statement+by+Third+Party&dateFiled=2025-01-02:
RVNC
real777mellon real777mellon 14 minutes ago
Dude what the heck are you talking about you wanted to know who was suing me I was saying about someone else. You're barking at me for taking time to explain a situation that's annoying but is what it is? Why are you thinking I'm attacking people and no I am not making any trouble for me. I'm making
LEHNQ
joyceschoice joyceschoice 14 minutes ago
He's not only implying it, he's crowing it through Stankonia capital and other message boards. How relevant his posts are to the Lehman CT's end game is a mystery to me. There is a hysterical component to his postings that makes wonder if its very personal.
LEHNQ
thistraderknowsall thistraderknowsall 15 minutes ago
BITCOIN is just in the recovery PHASE of $125k for new years run up. ,

News also Mentioned SPELL crypto on Top5 list to soar to $1+ on latest valuation..

get in SPELL retire early!!! We rich!!
HoldEm777 HoldEm777 17 minutes ago
I been out of pocket for a while…. Explain this low interest credit line your talking about and when it came about if you would. Thanks
RDAR
wickw50 wickw50 17 minutes ago
Watching for three green days in a row to start this week...
GME
Monroe1 Monroe1 18 minutes ago
yes, it will get better after bankruptcy. I plan on buying in at that time or instruct my grand kids to do so.
PFE
jay_tee jay_tee 20 minutes ago
Put the bottle down Santa. The weekend is over
RNVA

Your Recent History

Delayed Upgrade Clock